• OPEN AN ACCOUNT
A+| A| A-|
Indian Indices
Sensex
75,977.32 -32.38
( -0.04%)
Global Indices
Nasdaq
50,493.86 -106.84
(-0.21%)
Dow Jones
7,540.47 46.00
(0.61%)
Hang Seng
64,932.04 -226.15
(-0.35%)
Nikkei 225
10,499.42 33.16
(0.32%)
Forex
USD-INR
95.26 -0.35
(-0.37%)
EUR-INR
110.89 -0.08
(-0.07%)
GBP-INR
128.53 0.11
(0.08%)
JPY-INR
0.60 0.00
(-0.21%)

EQUITY - MARKET SCREENER

Ipca Laboratories Ltd
Industry :  Pharmaceuticals - Indian - Bulk Drugs & Formln
BSE Code
ISIN Demat
Book Value()
524494
INE571A01038
291.9817605
NSE Symbol
P/E(TTM)
Mar.Cap( Cr.)
IPCALAB
39.81
39988.86
EPS(TTM)
Face Value()
Div & Yield %
39.59
1
0.25
 

cinevista ltd
D-Link India consolidated net profit rises 0.66% in the March 2026 quarter
May 09,2026
Net profit of D-Link India rose 0.66% to Rs 27.61 crore in the quarter ended March 2026 as against Rs 27.43 crore during the previous quarter ended March 2025. Sales rose 20.00% to Rs 443.71 crore in the quarter ended March 2026 as against Rs 369.76 crore during the previous quarter ended March 2025.

For the full year,net profit declined 0.19% to Rs 104.06 crore in the year ended March 2026 as against Rs 104.26 crore during the previous year ended March 2025. Sales rose 13.14% to Rs 1565.70 crore in the year ended March 2026 as against Rs 1383.86 crore during the previous year ended March 2025.

ParticularsQuarter EndedYear Ended
Mar. 2026Mar. 2025% Var.Mar. 2026Mar. 2025% Var.
Sales443.71369.76 20 1565.701383.86 13
OPM %7.908.78 -8.429.18 -
PBDT38.6838.77 0 147.22146.62 0
PBT36.8437.05 -1 140.06139.68 0
NP27.6127.43 1 104.06104.26 0